-+ 0.00%
-+ 0.00%
-+ 0.00%

*Arrowhead Pharma: Voucher to Be Used to Accelerate Review of Planned sNDA for Plozasiran in Severe Hypertriglyceridemia >ARWR

Dow Jones·08/04/2026 20:00:00

登录查看新闻详情